Biotech · Public company · New Haven, CT, US

Veradermics, Inc

Ticker MANE · SEC CIK 0001827635

Track this companyFree. Adds Veradermics, Inc to your Dealase workspace and tells you when its record changes.

Clinical trials54 recruiting or active

Pipeline programs6From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline6

VDPHL01Phase 3 · Androgenetic AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
VDPHL01 BIDPhase 3 · Androgenetic Alopecia (AGA)ClinicalTrials.gov · fetched Nov 12, 2026
VDPHL01 QDPhase 3 · Androgenetic Alopecia (AGA)ClinicalTrials.gov · fetched Nov 12, 2026
VDMN-21 Patch High DosePhase 2 · Verruca VulgarisClinicalTrials.gov · fetched Nov 12, 2026
VDMN-21 Patch Low DosePhase 2 · Verruca VulgarisClinicalTrials.gov · fetched Nov 12, 2026
Vehicle PatchPhase 2 · Verruca VulgarisClinicalTrials.gov · fetched Nov 12, 2026

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)PHASE3 · ACTIVE_NOT_RECRUITING · started Jul 25, 2025ClinicalTrials.gov NCT07146022 · fetched Nov 12, 2026
Safety and Efficacy of VDPHL01 in Males With AGAPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 11, 2025ClinicalTrials.gov NCT06972264 · fetched Nov 12, 2026
Efficacy and Safety of VDPHL01 in Males With AGAPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Nov 6, 2024ClinicalTrials.gov NCT06724614 · fetched Nov 12, 2026
Safety and Efficacy of VDPHL01 in Males and Females With AGAPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 8, 2024ClinicalTrials.gov NCT06527365 · fetched Nov 12, 2026
Safety and Efficacy of VDMN-21 Patch in Subjects With Common WartsPHASE2 · COMPLETED · started Feb 28, 2023ClinicalTrials.gov NCT05799157 · fetched Nov 12, 2026